Viewing StudyNCT04068753



Ignite Creation Date: 2024-05-06 @ 1:35 PM
Last Modification Date: 2024-10-26 @ 1:16 PM
Study NCT ID: NCT04068753
Status: RECRUITING
Last Update Posted: 2024-05-10
First Post: 2019-08-22

Brief Title: Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive Cervix Cancer
Sponsor: University of Oklahoma
Organization: University of Oklahoma

Conditions & Keywords Data

Conditions:
Name
Progressive Cervix Cancer
Recurrent Cervix Cancer
Keywords:
Name View
dostarlimab View
Cervix Cancer View
Niraparib View